Preparing for the worst while hoping for the best: the relevance of hope in the heart failure illness trajectory
MetadataShow full item record
Background: Patients with heart failure have higher mortality rates than those with most malignant diseases. The heart failure illness trajectory is one of gradual decline characterized by unpredictable events such as acute decompensation of heart failure or a sudden cardiac death. Health professionals have an obligation to give patients and their families concise and honest information concerning their prognosis. The challenge exists to give what ostensibly may seem a bleak prognosis within a context of hope and optimism. Aim: To explore the role of hope in heart disease and the potential utility of this construct in the development of nursing interventions. Methods: The electronic databases CINAHL, MEDLINE, EmBASE, and PSYCHlit were searched from 1982 to August 2004 using the key words ‘‘hope,’’ ‘‘hopelessness,’’ ‘‘heart disease,’’ and ‘‘heart failure.’’ Articles were subsequently sorted to meet the inclusion criteria of (1) a philosophical discussion of the construct of hope and/or (2) investigation of hope in heart disease. Results: This search retrieved 768 articles, and 24 met the inclusion criteria. Key findings from the review indicate that ‘‘hope’’ and ‘‘hopelessness’’ are underdeveloped, yet important constructs and conceptually linked with depression and spirituality. Intriguing findings from descriptive, observational studies have demonstrated the positive impact of expression of hope on cardiovascular outcomes. These findings need to be validated in randomized controlled trials. Conclusions: This critical literature review has determined that ‘‘hope’’ is strongly associated with the individual’s future orientation. Increased understanding of this concept may assist in refining patient-focused interventions and developing therapeutic strategies to enhance hope.
Showing items related by title, author, creator and subject.
Prediction of heart failure by serum amino-terminal-pro-b-type natriuretic peptide (nt-probnp): an interim analysis of the screening evaluation of the evolution of new heart failure (screen-hf) studyCampbell, D.; McGrady, M.; Prior, D.; Coller, J.; Sheil, L.; Boffa, U.; Wolfe, R.; Reid, Christopher; Krum, H. (2015)Serum NT-proBNP level predicts heart failure. The SCREEN-HF study is a community-based cohort study that aims to identify an appropriate threshold NT-proBNP level for stratification of individuals into high and low risk ...
Du, HuiYun (2011)Chronic heart failure is a complex and multifaceted clinical syndrome and impacts adversely on health related quality of life and also increases the risk of hospitalisation and major acute coronary events. Self-care in ...
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline CharacteristicsLonn, E.; Bosch, J.; Pogue, J.; Avezum, A.; Chazova, I.; Dans, A.; Diaz, R.; Fodor, G.; Held, C.; Jansky, P.; Keltai, M.; Keltai, K.; Kunti, K.; Kim, J.; Leiter, L.; Lewis, B.; Liu, L.; Lopez-Jaramillo, P.; Pais, P.; Parkhomenko, A.; Peters, R.; Piegas, L.; Reid, Christopher; Sliwa, K.; Toff, W.; Varigos, J.; Xavier, D.; Yusoff, K.; Zhu, J.; Dagenais, G.; Yusuf, S.; HOPE-3 Investigators (2015)BACKGROUND: Cholesterol and blood pressure (BP) can be effectively and safely lowered with statin drugs and BP-lowering drugs, reducing major cardiovascular (CV) events by 20%-30% within 5 years in high-risk individuals. ...